Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2

NATerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 3, 2014

Primary Completion Date

July 12, 2021

Study Completion Date

February 14, 2022

Conditions
Blood Disorders
Interventions
OTHER

Patient-Centered Medical Home (PCMH)

Subjects will receive their conditioning chemotherapy +/- radiation and stem cells in the hospital or day hospital, after which they will receive care during the neutropenic/recovery period at home. Advanced Practice Providers (APP) will travel to subjects' homes in the morning, where they will perform the same daily assessment as standard care. They will draw labs and bring them back to the hospital for processing. When results are available, a second home visit is made to deliver necessary interventions. Subjects will have internet access through cellular-networked iPads and have daily videoconferences with their physicians. Daily follow up at home will continue until discharge as per above criteria.

OTHER

Standard Care

Subjects will receive their conditioning chemotherapy +/- radiation and stem cells in the hospital or day hospital, after which they will receive care during the neutropenic/recovery period inpatient or outpatient. Advanced practice providers (APPs) will perform histories and physical exams. Nurses will collect labs and inpatient rounds occur twice daily, or for outpatients receiving care through our outpatient clinics, a healthcare provider typically sees them daily for the first month following transplant or discharge from the day hospital.

Trial Locations (1)

27705

Duke University Adult Bone Marrow Transplant Clinic, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER